Authors: Akito Nozaki Manabu Morimoto Masaaki Kondo Takashi Oshima Kazushi Numata Shin Fujisawa Takeshi Kaneko Eiji Miyajima Satoshi Morita Kyoko Mori Masanori Ikeda Nobuyuki Kato Katsuaki Tanaka
Publish Date: 2010/03/05
Volume: 155, Issue: 4, Pages: 601-605
Abstract
Hepatitis C virus HCV is the main causative agent of chronic liver disease which may develop into liver cirrhosis and hepatocellular carcinoma By using a recently developed reporter assay system in which genomelength HCV RNA replicates efficiently we found that hydroxyurea HU a DNA synthesis inhibitor inhibited HCV RNA replication Moreover we demonstrated that the antiHCV activity of the combination of IFNalpha and HU was higher than that of IFNalpha alone These results suggest that HU may be an effective antiHCV reagent that can be used not only singly but also in combination with IFNalpha to treat chronic hepatitis C
Keywords: